Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q3 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Bright Minds Biosciences Inc.
Market Cap
$475.46M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$476.17M
Operating Margin
-43.75%
TTM Avg
-69.37%
3Y Avg
-212.63%
5Y Avg
-278.07%
Market Cap
$474.72M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-8.04%
5Y Avg
-6.43%
Market Cap
$475.02M
Operating Margin
-36.19%
TTM Avg
-55.58%
3Y Avg
-82.00%
5Y Avg
-57.61%
Market Cap
$472.58M
Operating Margin
-0.73%
TTM Avg
-6.05%
3Y Avg
-13.09%
5Y Avg
-25.54%
Market Cap
$485.58M
Operating Margin
13.16%
TTM Avg
14.88%
3Y Avg
13.50%
5Y Avg
6.84%
Market Cap
$486.39M
Operating Margin
-7.33%
TTM Avg
-12.79%
3Y Avg
-23.47%
5Y Avg
-68.20%
Market Cap
$465.75M
Operating Margin
-47.95%
TTM Avg
-55.61%
3Y Avg
-74.90%
5Y Avg
-86.86%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $475.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| Arvinas, Inc. (ARVN)vs › | $476.17M | -43.75% | -69.37% | -212.63% | -278.07% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $474.72M | 0.00% | 0.00% | -8.04% | -6.43% |
| Alpha Teknova, Inc. (TKNO)vs › | $475.02M | -36.19% | -55.58% | -82.00% | -57.61% |
| Cerus Corporation (CERS)vs › | $472.58M | -0.73% | -6.05% | -13.09% | -25.54% |
| Kamada Ltd. (KMDA)vs › | $470.50M | 14.51% | 13.50% | 9.39% | 8.55% |
| Puma Biotechnology, Inc. (PBYI)vs › | $485.58M | 13.16% | 14.88% | 13.50% | 6.84% |
| Evolus, Inc. (EOLS)vs › | $486.39M | -7.33% | -12.79% | -23.47% | -68.20% |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | -47.95% | -55.61% | -74.90% | -86.86% |
| NRC Health (NRC)vs › | $457.04M | 10.53% | 20.52% | 24.67% | 27.45% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
